Literature DB >> 85459

Maternal serum alpha-fetoprotein and diabetes mellitus.

N J Wald, H Cuckle, J Boreham, G M Stirrat, A C Turnbull.   

Abstract

Maternal serum alpha-fetoprotein (AFP) levels were measured from 12 to 24 weeks gestation in 27 singleton pregnancies in women with insulin-dependent diabetes mellitus and 90 controls without diabetes who were matched for gestational age. The geometric mean AFP level among the diabetic pregnancies was 60 per cent of that in the controls, a difference which was statistically significant (P less than 0.01). The difference in AFP level between diabetic patients and controls was most marked in sera taken before 21 weeks gestation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85459     DOI: 10.1111/j.1471-0528.1979.tb10575.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuse.

Authors:  J N Macri; R V Kasturi; D A Krantz; E J Cook; J W Larsen
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

2.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  Prenatal detection of Down syndrome in younger women.

Authors:  D N Singh
Journal:  Indian J Pediatr       Date:  1989 Jul-Aug       Impact factor: 1.967

4.  Alpha-fetoprotein: a biochemical marker of fetal well-being.

Authors:  A Gupta; I C Verma; P S Menon
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.